Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
StageZero Life Sciences Ltd
T.SZLS
Alternate Symbol(s):
SZLSF
Healthcare
Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease...
(AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
TSX:SZLS - Post Discussion
StageZero Life Sciences Ltd
> FDA authorizes 1st Covid-19 home test
New Post
View:
Discussion
List
(12061)
•••
ScienceFirst
X
View Profile
View Bullboard History
Post by
ScienceFirst
on Dec 09, 2020 10:23pm
FDA authorizes 1st Covid-19 home test
FDA authorizes first over-the-counter, non-prescription Covid-19 test system for home use
(1333)
•••
Nailbiter1
X
View Profile
View Bullboard History
Comment by
Nailbiter1
on Dec 09, 2020 10:31pm
This post has been removed in accordance with Community Policy
(1333)
•••
Nailbiter1
X
View Profile
View Bullboard History
Comment by
Nailbiter1
on Dec 09, 2020 10:33pm
This post has been removed in accordance with Community Policy
(445)
•••
Liked2Think
X
View Profile
View Bullboard History
Comment by
Liked2Think
on Dec 10, 2020 2:59am
If this is real and I guess that it is then it will hurt us how could it not the price is cheap. then again can they really do all the tests that are needed? There little demonstration looks like a joke to me. And your telling me a test that you use a little quitip thing to barely go inside your nose is equivalent to what Stage and other do? Human error seems o plenty with
...more
(84)
•••
Jonnyboy85
X
View Profile
View Bullboard History
Comment by
Jonnyboy85
on Dec 10, 2020 6:19am
Thats just it, this won't touch our revenue stream. Just like all the other tests out there, they will have massive shortages and delays in reporting, not to mention less accuracy due to it being self performed rather than by a nurse/phlebotomist and supervised. And as far as I know, all our tests are all covered by insurance as well so costs to the end user are irrelevant anyway. There have
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >